The program targets innovation at the clinical stage for the design of disease outcome measures and patient stratification in prospective therapeutic trials, as well as enhancing clinical care and patient monitoring.
The Neurotherapeutic Innovations team will pursue two translational clinical research streams:
Dr. Antonia Carroll
Dr. Andy Shieh (SNAC)
Dr. Daneh Turner (GE Healthcare)
Dr. Luca Passamonti (Biogen)